Yichao Wan

1.6k total citations · 1 hit paper
45 papers, 1.3k citations indexed

About

Yichao Wan is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Yichao Wan has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 24 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Yichao Wan's work include Synthesis and biological activity (14 papers), Cell death mechanisms and regulation (10 papers) and Histone Deacetylase Inhibitors Research (7 papers). Yichao Wan is often cited by papers focused on Synthesis and biological activity (14 papers), Cell death mechanisms and regulation (10 papers) and Histone Deacetylase Inhibitors Research (7 papers). Yichao Wan collaborates with scholars based in China and United States. Yichao Wan's co-authors include Zilong Tang, Mi Yan, Yuanhua Li, Hao Fang, Tingting Liu, Hongjuan Chen, Xu Deng, Guiyun Duan, Chengcai Xia and Yuliang Xiao and has published in prestigious journals such as Analytical Chemistry, Chemical Communications and Journal of Colloid and Interface Science.

In The Last Decade

Yichao Wan

39 papers receiving 1.3k citations

Hit Papers

Indole: A privileged scaffold for the design of anti-canc... 2019 2026 2021 2023 2019 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yichao Wan China 18 828 609 172 74 70 45 1.3k
Ian Hutchinson United Kingdom 14 1.1k 1.4× 519 0.9× 131 0.8× 68 0.9× 57 0.8× 32 1.6k
Mirela Sedić Croatia 18 705 0.9× 514 0.8× 136 0.8× 58 0.8× 45 0.6× 49 1.3k
Palwinder Singh India 21 525 0.6× 378 0.6× 138 0.8× 79 1.1× 52 0.7× 51 1.0k
Hsueh‐Yun Lee Taiwan 21 821 1.0× 824 1.4× 320 1.9× 139 1.9× 60 0.9× 56 1.6k
Marko Marjanović Croatia 20 513 0.6× 599 1.0× 182 1.1× 62 0.8× 29 0.4× 34 1.2k
Dean Stamos United States 21 598 0.7× 704 1.2× 209 1.2× 104 1.4× 47 0.7× 30 1.4k
Renukadevi Patil United States 23 920 1.1× 640 1.1× 163 0.9× 200 2.7× 77 1.1× 48 1.7k
Brian E. Fink United States 17 687 0.8× 893 1.5× 426 2.5× 92 1.2× 109 1.6× 27 1.7k
Chune Dong China 26 1.1k 1.3× 729 1.2× 208 1.2× 64 0.9× 76 1.1× 85 1.8k
Julie M. Locke Australia 12 566 0.7× 272 0.4× 136 0.8× 67 0.9× 47 0.7× 16 804

Countries citing papers authored by Yichao Wan

Since Specialization
Citations

This map shows the geographic impact of Yichao Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yichao Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yichao Wan more than expected).

Fields of papers citing papers by Yichao Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yichao Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yichao Wan. The network helps show where Yichao Wan may publish in the future.

Co-authorship network of co-authors of Yichao Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Yichao Wan. A scholar is included among the top collaborators of Yichao Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yichao Wan. Yichao Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Hongjuan, et al.. (2025). Recent advances of small-molecule Mcl-1 inhibitors or degraders as promising anti-cancer agents (2018-present). European Journal of Medicinal Chemistry. 299. 118079–118079.
2.
Chen, Chen, Xiaochun Ma, Yichao Wan, et al.. (2025). Design, synthesis and evaluation of structural optimization derived HDAC6 isoform-selective inhibitor. Bioorganic Chemistry. 161. 108562–108562.
3.
Zeng, Peng, Guang Li, Xiaomei Zhao, et al.. (2024). Construction and catalysis role of a kinetic promoter based on lithium-insertion technology and proton exchange strategy for lithium-sulfur batteries. Journal of Colloid and Interface Science. 670. 519–529. 12 indexed citations
4.
Zhu, Jian, et al.. (2024). Kinetics enhancement of an advanced separator modified by vanadium-based MXene for Li-S batteries. Materials Letters. 375. 137238–137238. 2 indexed citations
5.
Zhang, Yanyan, et al.. (2024). Photoredox/Copper-Cocatalyzed Domino Annulation of Oxime Esters and NH4SCN: Access to Fully Substituted 2-Aminothiazoles. The Journal of Organic Chemistry. 89(20). 15187–15196.
6.
Chen, Hongjuan, et al.. (2023). Azaindole derivatives as potential kinase inhibitors and their SARs elucidation. European Journal of Medicinal Chemistry. 258. 115621–115621. 10 indexed citations
7.
Wan, Yichao, et al.. (2021). Sulfonamide derivatives as potential anti-cancer agents and their SARs elucidation. European Journal of Medicinal Chemistry. 226. 113837–113837. 134 indexed citations
8.
He, Yujing, et al.. (2020). Dual-target Inhibitors Based on BRD4: Novel Therapeutic Approaches for Cancer. Current Medicinal Chemistry. 28(9). 1775–1795. 22 indexed citations
9.
Wan, Yichao, et al.. (2020). 2-Aminothiazole: A privileged scaffold for the discovery of anti-cancer agents. European Journal of Medicinal Chemistry. 210. 112953–112953. 55 indexed citations
10.
Wan, Yichao, et al.. (2020). Discovery of novel indazole-acylsulfonamide hybrids as selective Mcl-1 inhibitors. Bioorganic Chemistry. 104. 104217–104217. 14 indexed citations
11.
Li, Yi, Ben Liu, Cuixia Xu, et al.. (2020). Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties. JBIC Journal of Biological Inorganic Chemistry. 25(4). 597–607. 28 indexed citations
12.
Wan, Yichao, et al.. (2019). Indole: A privileged scaffold for the design of anti-cancer agents. European Journal of Medicinal Chemistry. 183. 111691–111691. 408 indexed citations breakdown →
13.
Tang, Zilong, Xinxing Li, Yuan Yao, et al.. (2019). Design, synthesis, fungicidal activity and molecular docking studies of novel 2-((2-hydroxyphenyl)methylamino)acetamide derivatives. Bioorganic & Medicinal Chemistry. 27(12). 2572–2578. 20 indexed citations
14.
Wan, Yichao, Yuanhua Li, Zilong Tang, et al.. (2019). A new xanthene-based fluorescent probe with a red light emission for selectively detecting glutathione and imaging in living cells. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 223. 117265–117265. 14 indexed citations
15.
Wan, Yichao, et al.. (2018). Small-molecule Mcl-1 inhibitors: Emerging anti-tumor agents. European Journal of Medicinal Chemistry. 146. 471–482. 70 indexed citations
16.
Liu, Lulu, et al.. (2018). Discovery and development of substituted tyrosine derivatives as Bcl-2/Mcl-1 inhibitors. Bioorganic & Medicinal Chemistry. 26(17). 4907–4915. 13 indexed citations
17.
Tang, Zilong, et al.. (2017). Synthesis and Fungicidal Activity of 1-(Carbamoylmethyl)-2-aryl-3,1-benzoxazines. Molecules. 22(7). 1103–1103. 6 indexed citations
18.
Wan, Yichao, et al.. (2016). Improved binding affinities of pyrrolidine derivatives as Mcl-1 inhibitors by modifying amino acid side chains. Bioorganic & Medicinal Chemistry. 25(1). 138–152. 13 indexed citations
19.
Guan, Peng, Lei Wang, Xuben Hou, et al.. (2014). Improved antiproliferative activity of 1,3,4-thiadiazole-containing histone deacetylase (HDAC) inhibitors by introduction of the heteroaromatic surface recognition motif. Bioorganic & Medicinal Chemistry. 22(21). 5766–5775. 35 indexed citations
20.
Wan, Yichao, et al.. (2014). Antagonists of IAP Proteins: Novel Anti-Tumor Agents. Current Medicinal Chemistry. 21(34). 3877–3892. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026